MRI in giant cell (temporal) arteritis;Magnetresonanztomografie der arteriitis temporalis horton

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 179, Issue 7, 2007, Pages 703-711

  Bley, Thorsten Alexander ^a   Uhl, M ^a   Markl, M ^a   Frydrychowicz, A ^a   Langer, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Arteries; Giant cell arteritis; MR angiography; MR imaging; Vascular

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

COST EFFECTIVENESS ANALYSIS; GIANT CELL ARTERITIS; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TEMPORAL ARTERY;

ARTERIES; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TEMPORAL ARTERIES; TEMPORAL ARTERITIS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 34447635719     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963123     Document Type: Review

References (54)

1. Horton B, Magath T, Brown G. An undescribed form of arteritis of the temporal vessels. Proc Mayo Clin 1932; 7: 700-701
2. Salvarani C, Cantini F, Boiardi L et al. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347: 261-271
3. Salvarani C, Crowson CS, O'Fallon WM et al. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004; 51: 264-268
4. Reinhold-Keller E, Zeidler A, Gutfleisch J et al. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology 2000; 39: 1396-1402
5. Schmidt D. Arteriitis temporalis Horton. Diagnose, Differentialdiagnose, Therapie. St. Gallen: Elephas, 1995
6. Wollensak J. Arteriitis temporalis. Bücher des Augenarztes. F. Enke Verlag, 1981;Heft 87: 59
7. Wenkel H. Bilateral amaurosis in 11 patients with giant cell arteritis confirmed by arterial biopsy. Klin Monatsbl Augenheilkd 2001; 218: 658-661
8. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment. Arthritis Rheum 1998; 41: 1497-1504
9. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128
10. Bloch DA, Moses LE, Michel BA. Statistical approaches to classification. Methods for developing classification and other criteria rules. Arthritis Rheum 1990; 33: 1137-1144
11. Gelfand SG. American College of Rheumatology criteria for the diagnosis of vasculitis. Ann Intern Med 1999; 130: 861
12. Klein RG, Campbell RJ, Hunder GC et al. Skip lesions in temporal arteritis. Mayo Clin Proc 1976; 51: 504-510
13. Bley TA, Wieben O, Uhl M et al. Assessment of the cranial involvement pattern of cell arteritis with 3T magnetic resonance imaging. Arthritis Rheum 2005; 52: 2470-2477
14. Pfadenhauer K, Weber H. Giant cell arteritis of the occipital arteries - a prospective color coded duplex sonography study in 78 patients. J Neurol 2003; 250: 844-849
15. Ronthal M, Gonzalez RG, Smith RN et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2003. A 72-year-old man with repetitive strokes in the posterior circulation. N Engl J Med 2003; 349: 170-180
16. Bau JL, Ly JQ, Borstad GC et al. Giant cell arteritis. Am J Roentgenol 2003; 181: 742
17. Save-Soderbergh J, Malmvall BE, Andersson R et al. Giant cell arteritis as a cause of death. Report of nine cases. Jama 1986; 255: 493-496
18. Brack A, Martinez-Taboada V, Stanson A et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999; 42: 311-317
19. Bley TA, Warnatz K, Wieben O et al. High-resolution MRI in giant cell arteritis with multiple inflammatory stenoses in both calves. Rheumatology 2005; 44: 954-955
20. Schmidt WA, Natusch A, Moller DE et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol 2002; 20: 309-318
21. Schmidt WA, Kraft HE, Vorpahl K et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997; 337: 1336-1342
22. Karassa FB, Matsagas MI, Schmidt WA et al. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 2005; 142: 359-369
23. Salvarani C, Silingardi M, Ghirarduzzi A et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med 2002; 137: 232-238
24. Herborn CU, Kneifel S, Huismann TA. Takayasu-Aortitis mit Befall der Pulmonalarterien - Differenzialdiagnose zur Lungenembolie. Fortschr Röntgenstr 2001; 173: 960-962
25. Hu Z, Yang Q, Yang L et al. Cerebral infarction due to giant cell arteritis-three case reports. Angiology 2004; 55: 227-231
26. Herve F, Choussy V, Janvresse A et al. Aortic involvement in giant cell arteritis. A prospective follow-up of 11 patients using computed tomography. Rev Med Interne 2006; 27: 196-202
27. Walter MA, Melzer RA, Schindler C et al. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005; 32: 674-681
28. Belhocine T. 18FDG imaging of giant cell arteritis: usefulness of wholebody plus brain PET. Eur J Nucl Med Mol Imaging 2004; 31: 1055-1056
29. Blockmans D, Stroobants S, Maes A et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108: 246-249
30. Jones T. The role of positron emission tomography within the spectrum of medical imaging. Eur J Nucl Med 1996; 23: 207-211
31. Walter MA, Melzer RA, Schindler C et al. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl med Mol Imaging 2005; 32: 674-681
32. Moosig F, Czech N, Mehl C et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 2004; 63: 870-873
33. Reuter M, Biederer J, Both M et al. Radiologie der primären systemischen Vaskulitiden. Fortschr Röntgenstr 2003; 175: 1184-1192
34. Both M, Reinhold-Keller E, Muller-Hulsbeck S et al. Entzündliches Aortenbogensyndrom: Stenosediagnostik mittels kontrastmittelverstärkter 3D-MR-Angiographie im Vergleich mit der DSA. Fortschr Röntgenstr 2004; 176: 48-55
35. Fritz J, Eschmann M, Horger M. Moderne radiologische Diagnostik der Takayasu Arteriitis. Fortschr Röntgenstr 2005; 177: 1467-1472
36. Abolmaali N, Langenfeld M, Krahforst R et al. MRT der Gefäßwand der thorakalen Aorta: Korrelation zur Histologie und zum Transösophagealen Ultraschall. Erste Ergebnisse. Fortschr Röntgenstr 2002; 174: 568-572
37. Mitomo T, Funyu T, Takahashi Y et al. Giant cell arteritis and magnetic resonance angiography. Arthritis Rheum 1998; 41: 1702
38. Anders HJ, Sigl T, Sander A et al. Gadolinium contrast magnetic resonance imaging of the temporal artery in giant cell arteritis. J Rheumatol 1999; 26: 2287-2288
39. Bley TA, Wieben O, Uhl M et al. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. Am J Roentgenol 2005; 184: 283-287
40. Bley TA, Wieben O, Vaith P et al. Magnetic resonance imaging depicts mural inflammation of the temporal artery in giant cell arteritis. Arthritis Rheum 2004; 51: 1062-1063
41. Norris DG. High field human imaging. J Magn Reson Imaging 2003; 18: 519-529
42. Bley TA, Wieben O, Uhl M et al. Integrated head-thoracic vascular MRI at 3 T: Assessment of cranial, cervical and thoracic involvement of giant cell arteritis. MAGMA 2005; 18: 193-200
43. Willinek WA, Gieseke J, Falkenhausen M von et al. Sensitivity encoding (SENSE) for high spatial resolution time-of-flight MR angiography of the intracranial arteries at 3.0 T. Fortschr Röntgenstr 2004; 176: 21-26
44. Korosec FR, Frayne R, Grist TM et al. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996; 36: 345-351
45. Friese S, Klose U, Kastrup A et al. Kontrastmittelverstärkte MR-Angiographie (CE-MRA) der supraaortalen Arterien: Dosisreduktion bei einem Kontrastmittel hoher Relaxivität (Gd-BOPTA). Fortschr Röntgenstr 2003; 175: 1363-1367
46. Kreitner KF, Kunz RP, Weschler C et al. Systematische Analyse der Geometrie eines definierten Kontrastmittelbolus - Implikationen für die kontrastmittelverstärkte 3D-MR-Angiographie thorakaler Gefäße. Fortschr Röntgenstr 2005; 177: 646-654
47. Bley TA, Uhl M, Markl M et al. Diagnostic value of high resolution MRI in giant cell arteritis. Eur Radiol 2006; S1: 233
48. Achkar AA, Lie JT, Hunder GG et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994; 120: 987-992
49. Choe YH, Kim DK, Koh EM et al. Takayasu arteritis: diagnosis with MR imaging and MR angiography in acute and chronic active stages. J Magn Reson Imaging 1999; 10: 751-757
50. Pelc NJ, Herfkens RJ, Shimakawa A et al. Phase contrast cine magnetic resonance imaging. Magn Reson Q 1991; 7: 229-254
51. Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664-1672
52. Meller J, Strutz F, Siefker U et al. Early diagnosis and follow-up of aortitis with [18F] FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003; 30: 730-736
53. Meissner OA, Rieber J, Babaryka G et al. Intravaskuläre optische Kohärenztomographie: Unterscheidung verschiedener Plaquetypen und Vermessung von Gefäßdimensionen in atheriosklerotischen Unterschenkelarterien ex vivo. Fortschr Röntgenstr 2006; 178: 214-220
54. Ladd SC, Zenge M, Antoch G et al. MR-Ganzkörperdiagnostik. Fortschr Röntgenstr 2006; 178: 763-770